Cargando…

Primary breast cancer in a patient with Wilson disease: A case report

RATIONALE: Wilson disease (WD) is an autosomal recessive hereditary disease in which the patient usually has a reduced risk of developing cancer. In particular, with the exception of hepatocellular carcinoma and cholangiocarcinoma, the incidence of cancer is significantly lower in WD patients compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dong, Wang, Jun, Gao, Jinnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531091/
https://www.ncbi.nlm.nih.gov/pubmed/31083157
http://dx.doi.org/10.1097/MD.0000000000015266
_version_ 1783420752972742656
author Li, Dong
Wang, Jun
Gao, Jinnan
author_facet Li, Dong
Wang, Jun
Gao, Jinnan
author_sort Li, Dong
collection PubMed
description RATIONALE: Wilson disease (WD) is an autosomal recessive hereditary disease in which the patient usually has a reduced risk of developing cancer. In particular, with the exception of hepatocellular carcinoma and cholangiocarcinoma, the incidence of cancer is significantly lower in WD patients compared with the general population. This case study presents a rare case of WD complicated with primary breast cancer. PATIENT CONCERNS: A 40-year-old woman who was diagnosed with WD at 25 years of age found a lump in her left breast. She has a family history of cancer. DIAGNOSES: Ultrasound and mammography results were highly suggestive of a malignant lesion. After core needle biopsy, it was confirmed that she had invasive breast cancer. INTERVENTIONS: A modified radical mastectomy was performed for the left breast. As the tumor was defined as a stage IIa triple negative breast cancer, the patient would have been recommended epirubicin/cyclophosphamide + docetaxel for 8 cycles if WD was not a comorbidity. As the patient had cirrhosis and abnormal liver function, she was given paclitaxel weekly for 6 cycles instead. OUTCOMES: The patient showed good tolerance, and has not had a recurrence in 2 years. LESSONS: We reviewed the literature for studies of patients with WD complicated with cancers, and to our knowledge, this is the first report on WD complicated with breast cancer. The patient received chemotherapy even with liver dysfunction, which suggests that patients with WD can be safely treated with paclitaxel chemotherapy under close surveillance.
format Online
Article
Text
id pubmed-6531091
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-65310912019-06-25 Primary breast cancer in a patient with Wilson disease: A case report Li, Dong Wang, Jun Gao, Jinnan Medicine (Baltimore) Research Article RATIONALE: Wilson disease (WD) is an autosomal recessive hereditary disease in which the patient usually has a reduced risk of developing cancer. In particular, with the exception of hepatocellular carcinoma and cholangiocarcinoma, the incidence of cancer is significantly lower in WD patients compared with the general population. This case study presents a rare case of WD complicated with primary breast cancer. PATIENT CONCERNS: A 40-year-old woman who was diagnosed with WD at 25 years of age found a lump in her left breast. She has a family history of cancer. DIAGNOSES: Ultrasound and mammography results were highly suggestive of a malignant lesion. After core needle biopsy, it was confirmed that she had invasive breast cancer. INTERVENTIONS: A modified radical mastectomy was performed for the left breast. As the tumor was defined as a stage IIa triple negative breast cancer, the patient would have been recommended epirubicin/cyclophosphamide + docetaxel for 8 cycles if WD was not a comorbidity. As the patient had cirrhosis and abnormal liver function, she was given paclitaxel weekly for 6 cycles instead. OUTCOMES: The patient showed good tolerance, and has not had a recurrence in 2 years. LESSONS: We reviewed the literature for studies of patients with WD complicated with cancers, and to our knowledge, this is the first report on WD complicated with breast cancer. The patient received chemotherapy even with liver dysfunction, which suggests that patients with WD can be safely treated with paclitaxel chemotherapy under close surveillance. Wolters Kluwer Health 2019-05-13 /pmc/articles/PMC6531091/ /pubmed/31083157 http://dx.doi.org/10.1097/MD.0000000000015266 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Li, Dong
Wang, Jun
Gao, Jinnan
Primary breast cancer in a patient with Wilson disease: A case report
title Primary breast cancer in a patient with Wilson disease: A case report
title_full Primary breast cancer in a patient with Wilson disease: A case report
title_fullStr Primary breast cancer in a patient with Wilson disease: A case report
title_full_unstemmed Primary breast cancer in a patient with Wilson disease: A case report
title_short Primary breast cancer in a patient with Wilson disease: A case report
title_sort primary breast cancer in a patient with wilson disease: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531091/
https://www.ncbi.nlm.nih.gov/pubmed/31083157
http://dx.doi.org/10.1097/MD.0000000000015266
work_keys_str_mv AT lidong primarybreastcancerinapatientwithwilsondiseaseacasereport
AT wangjun primarybreastcancerinapatientwithwilsondiseaseacasereport
AT gaojinnan primarybreastcancerinapatientwithwilsondiseaseacasereport